Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05261802 · ClinicalTrials.gov registry record · NA
AVANCE-Houston FRAMEWorks Program Evaluation
A NA study of Adults, sponsored by Midwest Evaluation & Research.
- Completed
- Registry status
- NA
- Development phase
- 1,403
- Enrollment target
- 1
- Study location
NCT05261802 is a NA study of Adults that has completed, run by Midwest Evaluation & Research. The registered enrollment target is 1,403 participants, above the 123-participant average among 3 other Adults trials with a reported enrollment target (1041% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05261802, a NA study of Adults, has completed, sponsored by Midwest Evaluation & Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,403 participants
- Enrollment target
- 1
- Study location
Study Summary
AVANCE-Houston seeks to understand whether a standard or compressed schedule format for delivering the Survival Skills for Healthy Families curriculum better meets the needs of low-income adults to improve skill retention and, ultimately, to promote better outcomes for healthy family relationships and economic stability.
Conditions Studied
Interventions
- OTHER Descriptive Intervention
Study Locations (1)
Texas
- AVANCE-Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,403 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2025-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05261802
The ClinicalTrials.gov registry entry for NCT05261802 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,403 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 123-participant average among 3 other Adults trials with a reported enrollment target (1041% higher). The listed sponsor is Midwest Evaluation & Research, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adults appearing as the primary indexed condition, and to 1 intervention - of which Descriptive Intervention is the first listed.
NCT05261802 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05261802 about?
NCT05261802 is a clinical study titled "AVANCE-Houston FRAMEWorks Program Evaluation". AVANCE-Houston seeks to understand whether a standard or compressed schedule format for delivering the Survival Skills for Healthy Families curriculum better meets the needs of low-income adults to improve skill retention and, ultimately, to promote better outcomes for healthy family relationships a...
What is the current status of trial NCT05261802?
This trial is currently completed. It is a NA study. The enrollment target is 1,403 participants. The study started on 2021-04-01. Estimated completion is 2025-08-29.
What conditions does trial NCT05261802 study?
This clinical trial studies the following conditions: Adults.
What interventions are being tested in trial NCT05261802?
The interventions under investigation include: Descriptive Intervention (OTHER).
Who is sponsoring clinical trial NCT05261802?
This trial is sponsored by Midwest Evaluation & Research, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05261802 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.